Insulet has commenced patient enrolment in its pivotal EVOLVE study, evaluating a fully closed-loop AID system for adults with T2D.
InspireMD has issued a voluntary recall of its CGuard Prime 135cm carotid stent delivery system in the US, following consultation with the US FDA.
TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results